WAVE LIFE SCIENCES LTD. Comprehensive Income
WAVE LIFE SCIENCES LTD. (WVE) reported Comprehensive Income of -$69.27 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-07-30
- WAVE LIFE SCIENCES LTD. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$69.27M.
- WAVE LIFE SCIENCES LTD. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$26.09M.
- WAVE LIFE SCIENCES LTD. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$53.24M, a 282.64% decline year-over-year.
- WAVE LIFE SCIENCES LTD. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$53.88M.
- WAVE LIFE SCIENCES LTD. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$204.37M.
- WAVE LIFE SCIENCES LTD. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$97.15M.
- WAVE LIFE SCIENCES LTD. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$57.61M.
- WAVE LIFE SCIENCES LTD. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$162.03M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$69.27M 10-Q · filed 2026-07-30 | -$95.36M 10-Q · filed 2026-07-30 | -$148.60M derived: sum of 3 quarters · filed 2026-07-30 | -$202.48M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$26.09M 10-Q · filed 2026-04-28 | -$79.33M derived: sum of 2 quarters · filed 2026-04-28 | -$133.21M derived: sum of 3 quarters · filed 2026-04-28 | -$183.64M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$53.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$107.12M derived: sum of 2 quarters · filed 2026-02-26 | -$157.55M derived: sum of 3 quarters · filed 2026-07-30 | -$204.37M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$53.88M 10-Q · filed 2025-11-10 | -$104.31M derived: sum of 2 quarters · filed 2026-07-30 | -$151.13M 10-Q · filed 2025-11-10 | -$121.98M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | -$50.43M 10-Q · filed 2026-07-30 | -$97.25M 10-Q · filed 2026-07-30 | -$68.10M derived: sum of 3 quarters · filed 2026-07-30 | -$129.76M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$46.82M 10-Q · filed 2026-04-28 | -$17.67M derived: sum of 2 quarters · filed 2026-04-28 | -$79.33M derived: sum of 3 quarters · filed 2026-04-28 | -$112.33M derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2024-12-31 | $29.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$32.51M derived: sum of 2 quarters · filed 2026-02-26 | -$65.51M derived: sum of 3 quarters · filed 2026-02-26 | -$97.15M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$61.66M 10-Q · filed 2025-11-10 | -$94.66M derived: sum of 2 quarters · filed 2025-11-10 | -$126.30M 10-Q · filed 2025-11-10 | -$142.49M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$33.00M 10-Q · filed 2025-07-30 | -$64.64M 10-Q · filed 2025-07-30 | -$80.83M derived: sum of 3 quarters · filed 2026-02-26 | -$73.61M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$31.63M 10-Q · filed 2025-05-08 | -$47.83M derived: sum of 2 quarters · filed 2026-02-26 | -$40.61M derived: sum of 3 quarters · filed 2026-02-26 | -$61.81M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$16.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$8.98M derived: sum of 2 quarters · filed 2026-02-26 | -$30.18M derived: sum of 3 quarters · filed 2026-02-26 | -$57.61M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $7.22M 10-Q · filed 2024-11-12 | -$13.98M derived: sum of 2 quarters · filed 2024-11-12 | -$41.41M 10-Q · filed 2024-11-12 | -$85.03M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-06-30 | -$21.20M 10-Q · filed 2024-08-08 | -$48.63M 10-Q · filed 2024-08-08 | -$92.25M derived: sum of 3 quarters · filed 2025-03-04 | -$131.32M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-03-31 | -$27.43M 10-Q · filed 2024-05-10 | -$71.04M derived: sum of 2 quarters · filed 2025-03-04 | -$110.12M derived: sum of 3 quarters · filed 2025-03-04 | -$151.56M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2022-12-31 | -$43.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$82.69M derived: sum of 2 quarters · filed 2025-03-04 | -$124.13M derived: sum of 3 quarters · filed 2025-03-04 | -$162.03M 10-K · filed 2025-03-04 | ||||
| 2022-09-30 | -$39.08M 10-Q · filed 2023-11-09 | -$80.52M derived: sum of 2 quarters · filed 2023-11-09 | -$118.42M 10-Q · filed 2023-11-09 | -$153.28M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$41.44M 10-Q · filed 2023-08-03 | -$79.34M 10-Q · filed 2023-08-03 | -$114.20M derived: sum of 3 quarters · filed 2023-08-03 | -$120.44M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | -$37.90M 10-Q · filed 2023-05-03 | -$72.76M derived: sum of 2 quarters · filed 2023-05-03 | -$79.00M derived: sum of 3 quarters · filed 2023-05-03 | -$117.77M derived: sum of 4 quarters · filed 2023-05-03 | ||||
| 2021-12-31 | -$34.86M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$41.10M derived: sum of 2 quarters · filed 2023-03-23 | -$79.87M derived: sum of 3 quarters · filed 2023-03-23 | -$122.45M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | -$6.24M 10-Q · filed 2022-11-10 | -$45.01M derived: sum of 2 quarters · filed 2022-11-10 | -$87.59M 10-Q · filed 2022-11-10 | -$116.29M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$38.77M 10-Q · filed 2022-08-11 | -$81.35M 10-Q · filed 2022-08-11 | -$110.05M derived: sum of 3 quarters · filed 2022-08-11 | -$143.13M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$42.58M 10-Q · filed 2022-05-12 | -$71.28M derived: sum of 2 quarters · filed 2022-05-12 | -$104.36M derived: sum of 3 quarters · filed 2022-05-12 | -$144.88M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$28.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$61.78M derived: sum of 2 quarters · filed 2022-03-03 | -$102.30M derived: sum of 3 quarters · filed 2022-03-03 | -$149.79M 10-K · filed 2022-03-03 | ||||
| 2020-09-30 | -$33.08M 10-Q · filed 2021-11-10 | -$73.60M derived: sum of 2 quarters · filed 2021-11-10 | -$121.09M 10-Q · filed 2021-11-10 | -$177.87M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$40.52M 10-Q · filed 2021-08-05 | -$88.01M 10-Q · filed 2021-08-05 | -$144.79M derived: sum of 3 quarters · filed 2021-08-05 | -$195.52M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$47.49M 10-Q · filed 2021-05-13 | -$104.27M derived: sum of 2 quarters · filed 2021-05-13 | -$155.00M derived: sum of 3 quarters · filed 2021-05-13 | -$196.91M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$56.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$107.51M derived: sum of 2 quarters · filed 2021-03-04 | -$149.42M derived: sum of 3 quarters · filed 2021-03-04 | -$193.52M 10-K · filed 2021-03-04 | ||||
| 2019-09-30 | -$50.72M 10-Q · filed 2020-11-09 | -$92.64M derived: sum of 2 quarters · filed 2020-11-09 | -$136.74M 10-Q · filed 2020-11-09 | -$174.65M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$41.91M 10-Q · filed 2020-08-10 | -$86.02M 10-Q · filed 2020-08-10 | -$123.93M derived: sum of 3 quarters · filed 2020-08-10 | -$161.58M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$44.10M 10-Q · filed 2020-05-11 | -$82.02M derived: sum of 2 quarters · filed 2020-05-11 | -$119.67M derived: sum of 3 quarters · filed 2020-05-11 | -$155.53M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | -$37.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$75.57M derived: sum of 2 quarters · filed 2020-03-02 | -$111.42M derived: sum of 3 quarters · filed 2020-03-02 | -$146.62M 10-K · filed 2020-03-02 | ||||
| 2018-09-30 | -$37.65M 10-Q · filed 2019-11-05 | -$73.51M derived: sum of 2 quarters · filed 2019-11-05 | -$108.70M 10-Q · filed 2019-11-05 | -$139.11M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | -$35.86M 10-Q · filed 2019-08-06 | -$71.05M 10-Q · filed 2019-08-06 | -$101.45M derived: sum of 3 quarters · filed 2020-03-02 | -$126.95M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | -$35.19M 10-Q · filed 2019-05-10 | -$65.60M derived: sum of 2 quarters · filed 2020-03-02 | -$91.09M derived: sum of 3 quarters · filed 2020-03-02 | -$115.68M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | -$30.41M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$55.90M derived: sum of 2 quarters · filed 2020-03-02 | -$80.49M derived: sum of 3 quarters · filed 2020-03-02 | -$101.57M 10-K · filed 2020-03-02 | -$101.63M 10-K · filed 2018-03-12 | |||
| 2017-09-30 | -$25.49M 10-Q · filed 2018-11-09 | -$26.13M 10-Q · filed 2017-11-09 | -$50.09M derived: sum of 2 quarters · filed 2018-11-09 | -$71.17M 10-Q · filed 2018-11-09 | -$71.81M 10-Q · filed 2017-11-09 | -$90.26M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | -$24.59M 10-Q · filed 2018-08-09 | -$24.69M 10-Q · filed 2017-08-09 | -$45.67M 10-Q · filed 2018-08-09 | -$45.67M 10-Q · filed 2017-08-09 | -$64.76M derived: sum of 3 quarters · filed 2019-03-01 | -$82.29M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | -$21.08M 10-Q · filed 2018-05-09 | -$20.98M 10-Q · filed 2017-05-10 | -$40.17M derived: sum of 2 quarters · filed 2019-03-01 | -$57.70M derived: sum of 3 quarters · filed 2019-03-01 | -$69.24M derived: sum of 4 quarters · filed 2019-03-01 | |||
| 2016-12-31 | -$19.09M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$36.62M derived: sum of 2 quarters · filed 2019-03-01 | -$48.16M derived: sum of 3 quarters · filed 2019-03-01 | -$55.99M 10-K · filed 2019-03-01 | -$55.73M 10-K · filed 2017-03-16 | |||
| 2016-09-30 | -$17.53M 10-Q · filed 2017-11-09 | -$29.07M derived: sum of 2 quarters · filed 2017-11-09 | -$36.90M 10-Q · filed 2017-11-09 | -$44.01M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-06-30 | -$11.54M 10-Q · filed 2017-08-09 | -$19.38M 10-Q · filed 2017-08-09 | -$26.48M derived: sum of 3 quarters · filed 2018-03-12 | -$31.41M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | -$7.84M 10-Q · filed 2017-05-10 | -$14.94M derived: sum of 2 quarters · filed 2018-03-12 | -$19.86M derived: sum of 3 quarters · filed 2018-03-12 | -$23.56M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2015-12-31 | -$7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$12.03M derived: sum of 2 quarters · filed 2018-03-12 | -$15.72M derived: sum of 3 quarters · filed 2018-03-12 | -$19.21M 10-K · filed 2018-03-12 | ||||
| 2015-09-30 | -$4.93M 10-Q · filed 2016-11-09 | -$8.62M derived: sum of 2 quarters · filed 2016-11-09 | -$12.11M 10-Q · filed 2016-11-09 | -$13.90M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | -$3.69M 10-Q · filed 2016-08-15 | -$7.19M 10-Q · filed 2016-08-15 | -$8.97M derived: sum of 3 quarters · filed 2017-03-16 | -$10.38M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | -$3.49M 10-Q · filed 2016-05-16 | -$5.28M derived: sum of 2 quarters · filed 2017-03-16 | -$6.69M derived: sum of 3 quarters · filed 2017-03-16 | |||||
| 2014-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$3.19M derived: sum of 2 quarters · filed 2017-03-16 | -$5.40M 10-K · filed 2017-03-16 | |||||
| 2014-09-30 | -$1.41M 10-Q · filed 2015-12-17 | -$3.62M 10-Q · filed 2015-12-17 | ||||||
| 2013-12-31 | -$3.18M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |